Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 135 Pages
Report ld: 6482900
Request Sample
Customized Report
Ergometrine Maleate API Market Size(US$)

CAGR 2026-2032
3.8%
Market Size,2032
USD 195
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Ergometrine Maleate API market was valued at US$ 151 million in 2025 and is anticipated to reach US$ 195 million by 2032, at a CAGR of 3.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ergometrine Maleate API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Ergometrine maleate API is the active pharmaceutical ingredient of the medication ergometrine maleate, which is used primarily in obstetrics and gynecology. As mentioned earlier, ergometrine maleate helps prevent or treat postpartum hemorrhage (excessive bleeding) after childbirth by inducing uterine contractions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Ergometrine Maleate API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ergometrine Maleate API. The Ergometrine Maleate API market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ergometrine Maleate API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ergometrine Maleate API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Ergometrine Maleate API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Ergometrine Maleate API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Ergometrine Maleate API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Ergometrine Maleate API Market Overview
1.1 Product Definition
1.2 Ergometrine Maleate API by Type
1.2.1 Global Ergometrine Maleate API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity Less than 98%
1.2.3 Purity 98%
1.2.4 Purity Greater than 98%
1.3 Ergometrine Maleate API by Application
1.3.1 Global Ergometrine Maleate API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Injection
1.3.3 Tablet
1.4 Global Market Growth Prospects
1.4.1 Global Ergometrine Maleate API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Ergometrine Maleate API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Ergometrine Maleate API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Ergometrine Maleate API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ergometrine Maleate API Production Market Share by Manufacturers (2021–2026)
2.2 Global Ergometrine Maleate API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Ergometrine Maleate API, Industry Ranking, 2024 vs 2025
2.4 Global Ergometrine Maleate API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Ergometrine Maleate API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Ergometrine Maleate API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Ergometrine Maleate API, Product Offerings and Applications
2.8 Global Key Manufacturers of Ergometrine Maleate API, Date of Entry into the Industry
2.9 Ergometrine Maleate API Market Competitive Situation and Trends
2.9.1 Ergometrine Maleate API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Ergometrine Maleate API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Ergometrine Maleate API Production by Region
3.1 Global Ergometrine Maleate API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Ergometrine Maleate API Production Value by Region (2021–2032)
3.2.1 Global Ergometrine Maleate API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Ergometrine Maleate API by Region (2027–2032)
3.3 Global Ergometrine Maleate API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Ergometrine Maleate API Production Volume by Region (2021–2032)
3.4.1 Global Ergometrine Maleate API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Ergometrine Maleate API by Region (2027–2032)
3.5 Global Ergometrine Maleate API Market Price Analysis by Region (2021–2032)
3.6 Global Ergometrine Maleate API Production, Value, and Year-over-Year Growth
3.6.1 North America Ergometrine Maleate API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Ergometrine Maleate API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Ergometrine Maleate API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Ergometrine Maleate API Production Value Estimates and Forecasts (2021–2032)
4 Ergometrine Maleate API Consumption by Region
4.1 Global Ergometrine Maleate API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Ergometrine Maleate API Consumption by Region (2021–2032)
4.2.1 Global Ergometrine Maleate API Consumption by Region (2021–2026)
4.2.2 Global Ergometrine Maleate API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Ergometrine Maleate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Ergometrine Maleate API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ergometrine Maleate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Ergometrine Maleate API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ergometrine Maleate API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Ergometrine Maleate API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ergometrine Maleate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Ergometrine Maleate API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Ergometrine Maleate API Production by Type (2021–2032)
5.1.1 Global Ergometrine Maleate API Production by Type (2021–2026)
5.1.2 Global Ergometrine Maleate API Production by Type (2027–2032)
5.1.3 Global Ergometrine Maleate API Production Market Share by Type (2021–2032)
5.2 Global Ergometrine Maleate API Production Value by Type (2021–2032)
5.2.1 Global Ergometrine Maleate API Production Value by Type (2021–2026)
5.2.2 Global Ergometrine Maleate API Production Value by Type (2027–2032)
5.2.3 Global Ergometrine Maleate API Production Value Market Share by Type (2021–2032)
5.3 Global Ergometrine Maleate API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Ergometrine Maleate API Production by Application (2021–2032)
6.1.1 Global Ergometrine Maleate API Production by Application (2021–2026)
6.1.2 Global Ergometrine Maleate API Production by Application (2027–2032)
6.1.3 Global Ergometrine Maleate API Production Market Share by Application (2021–2032)
6.2 Global Ergometrine Maleate API Production Value by Application (2021–2032)
6.2.1 Global Ergometrine Maleate API Production Value by Application (2021–2026)
6.2.2 Global Ergometrine Maleate API Production Value by Application (2027–2032)
6.2.3 Global Ergometrine Maleate API Production Value Market Share by Application (2021–2032)
6.3 Global Ergometrine Maleate API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Teva API
7.1.1 Teva API Ergometrine Maleate API Company Information
7.1.2 Teva API Ergometrine Maleate API Product Portfolio
7.1.3 Teva API Ergometrine Maleate API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Teva API Main Business and Markets Served
7.1.5 Teva API Recent Developments/Updates
7.2 LGC
7.2.1 LGC Ergometrine Maleate API Company Information
7.2.2 LGC Ergometrine Maleate API Product Portfolio
7.2.3 LGC Ergometrine Maleate API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 LGC Main Business and Markets Served
7.2.5 LGC Recent Developments/Updates
7.3 Triveni Interchem
7.3.1 Triveni Interchem Ergometrine Maleate API Company Information
7.3.2 Triveni Interchem Ergometrine Maleate API Product Portfolio
7.3.3 Triveni Interchem Ergometrine Maleate API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Triveni Interchem Main Business and Markets Served
7.3.5 Triveni Interchem Recent Developments/Updates
7.4 Bolise
7.4.1 Bolise Ergometrine Maleate API Company Information
7.4.2 Bolise Ergometrine Maleate API Product Portfolio
7.4.3 Bolise Ergometrine Maleate API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Bolise Main Business and Markets Served
7.4.5 Bolise Recent Developments/Updates
7.5 Sichuan Renan Pharmaceutical
7.5.1 Sichuan Renan Pharmaceutical Ergometrine Maleate API Company Information
7.5.2 Sichuan Renan Pharmaceutical Ergometrine Maleate API Product Portfolio
7.5.3 Sichuan Renan Pharmaceutical Ergometrine Maleate API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Sichuan Renan Pharmaceutical Main Business and Markets Served
7.5.5 Sichuan Renan Pharmaceutical Recent Developments/Updates
7.6 Chemfish
7.6.1 Chemfish Ergometrine Maleate API Company Information
7.6.2 Chemfish Ergometrine Maleate API Product Portfolio
7.6.3 Chemfish Ergometrine Maleate API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Chemfish Main Business and Markets Served
7.6.5 Chemfish Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ergometrine Maleate API Industry Chain Analysis
8.2 Ergometrine Maleate API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ergometrine Maleate API Production Modes and Processes
8.4 Ergometrine Maleate API Sales and Marketing
8.4.1 Ergometrine Maleate API Sales Channels
8.4.2 Ergometrine Maleate API Distributors
8.5 Ergometrine Maleate API Customer Analysis
9 Ergometrine Maleate API Market Dynamics
9.1 Ergometrine Maleate API Industry Trends
9.2 Ergometrine Maleate API Market Drivers
9.3 Ergometrine Maleate API Market Challenges
9.4 Ergometrine Maleate API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Ergometrine Maleate API was estimated to be worth US$ 151 million in 2025 and is projected to reach US$ 195 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 130
USD 3950.00
(Single User License)
The global Ergometrine Maleate API market size was US$ 146 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 76
USD 4250.00
(Single User License)
The global Ergometrine Maleate API market is projected to grow from US$ 146 million in 2024 to US$ 189 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 134
USD 4900.00
(Single User License)
The global market for Ergometrine Maleate API was estimated to be worth US$ 146 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 95
USD 3950.00
(Single User License)
The global market for Ergometrine Maleate API was valued at US$ 146 million in the year 2024 and is projected to reach a revised size of US$ 189 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published Date: 2025-01-13
Pages: 89
USD 2900.00
(Single User License)
Ergometrine maleate API is the active pharmaceutical ingredient of the medication ergometrine maleate, which is used primarily in obstetrics and gynecology. As mentioned earlier, ergometrine maleate helps prevent or treat postpartum hemorrhage (excessive bleeding) after childbirth by inducing uterine contractions.
Published Date: 2024-02-05
Pages: 92
USD 2900.00
(Single User License)
The global market for Ergometrine Maleate API was estimated to be worth US$ 151 million in 2025 and is projected to reach US$ 195 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 130
The global Ergometrine Maleate API market size was US$ 146 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 76
The global Ergometrine Maleate API market is projected to grow from US$ 146 million in 2024 to US$ 189 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 134
The global market for Ergometrine Maleate API was estimated to be worth US$ 146 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 95
The global market for Ergometrine Maleate API was valued at US$ 146 million in the year 2024 and is projected to reach a revised size of US$ 189 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published: 2025-01-13
Pages: 89
Ergometrine maleate API is the active pharmaceutical ingredient of the medication ergometrine maleate, which is used primarily in obstetrics and gynecology. As mentioned earlier, ergometrine maleate helps prevent or treat postpartum hemorrhage (excessive bleeding) after childbirth by inducing uterine contractions.
Published: 2024-02-05
Pages: 92
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now